NCT02846961View on ClinicalTrials.gov

Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

280

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

December 31, 2020

Conditions
Inflammatory Bowel DiseaseUlcerative ColitisCrohn's Disease
Trial Locations (1)

41944

Kyungpook National University Hospital, Daegu

All Listed Sponsors
lead

Kyungpook National University Hospital

OTHER

NCT02846961 - Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter